Both in Pharmaceuticals
Organon & vs Viking Therapeutics
Over the past year OGN returned +106.4% and VKTX returned −23.0%; their daily moves had a correlation of 0.07.
OGN +106.4% VKTX −23.0%Growth of $1, one year, split-adjusted
| Metric | OGN | VKTX |
|---|---|---|
| Price | $13.85 | $27.73 |
| Market cap | $3.64B | $3.54B |
| Today | 0.00% | +6.29% |
| 1 month | +0.8% | −2.3% |
| 6 months | +3.3% | −14.1% |
| Year to date | +93.2% | −21.2% |
| 1 year | +106.4% | −23.0% |
| Revenue growth (YoY) | −1.7% | — |
| Gross margin | 55.2% | — |
| Net margin | 10.4% | — |
| P/E (TTM) | 17.1× | — |
| Price / sales | 0.6× | — |
| Net cash | -$7.10B | $709.2M |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.9% | 87.6% |
| Short % of float | 7.2% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).